Literature DB >> 11392613

Generation and pharmacological analysis of M2 and M4 muscarinic receptor knockout mice.

J Gomeza1, L Zhang, E Kostenis, C C Felder, F P Bymaster, J Brodkin, H Shannon, B Xia, A Duttaroy, C X Deng, J Wess.   

Abstract

Muscarinic acetylcholine receptors (M1-M5) play important roles in the modulation of many key functions of the central and peripheral nervous system. To explore the physiological roles of the two Gi-coupled muscarinic receptors, we disrupted the M2 and M4 receptor genes in mice by using a gene targeting strategy. Pharmacological and behavioral analysis of the resulting mutant mice showed that the M2 receptor subtype is critically involved in mediating three of the most striking central muscarinic effects, tremor, hypothermia, and analgesia. These studies also indicated that M4 receptors are not critically involved in these central muscarinic responses. However, M4 receptor-deficient mice showed an increase in basal locomotor activity and greatly enhanced locomotor responses following drug-induced activation of D1 dopamine receptors. This observation is consistent with the concept that M4 receptors exert inhibitory control over D1 receptor-mediated locomotor stimulation, probably at the level of striatal projection neurons where the two receptors are known to be coexpressed. These findings emphasize the usefulness of gene targeting approaches to shed light on the physiological and pathophysiological roles of the individual muscarinic receptor subtypes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11392613     DOI: 10.1016/s0024-3205(01)01039-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  20 in total

1.  Decrease in heart adrenoceptor gene expression and receptor number as compensatory tool for preserved heart function and biological rhythm in M(2) KO animals.

Authors:  Jan Benes; Eva Varejkova; Vladimir Farar; Martina Novakova; Jaromir Myslivecek
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-10-24       Impact factor: 3.000

2.  Muscarinic receptor-activated cationic channels in murine ileal myocytes.

Authors:  A V Dresviannikov; T B Bolton; A V Zholos
Journal:  Br J Pharmacol       Date:  2006-08-07       Impact factor: 8.739

3.  Autonomic modulation of the electrical substrate in mice haploinsufficient for cardiac sodium channels: a model of the Brugada syndrome.

Authors:  Malcolm Finlay; Justine Bhar-Amato; Keat-Eng Ng; Diogo Santos; Michele Orini; Vishal Vyas; Peter Taggart; Andrew A Grace; Christopher L-H Huang; Pier D Lambiase; Andrew Tinker
Journal:  Am J Physiol Cell Physiol       Date:  2019-07-10       Impact factor: 4.249

4.  In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.

Authors:  Agostinho Lemos; Rita Melo; Antonio Jose Preto; Jose Guilherme Almeida; Irina Sousa Moreira; Maria Natalia Dias Soeiro Cordeiro
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

5.  The muscarinic acetylcholine receptor agonist BuTAC mediates antipsychotic-like effects via the M4 subtype.

Authors:  Marla L Watt; Linda Rorick-Kehn; David B Shaw; Karen M Knitowski; Anne T Quets; Amy K Chesterfield; David L McKinzie; Christian C Felder
Journal:  Neuropsychopharmacology       Date:  2013-08-02       Impact factor: 7.853

6.  Subcellular distribution of M2 muscarinic receptors in relation to dopaminergic neurons of the rat ventral tegmental area.

Authors:  Miguel Garzón; Virginia M Pickel
Journal:  J Comp Neurol       Date:  2006-10-20       Impact factor: 3.215

7.  Distinct muscarinic acetylcholine receptor subtypes contribute to stability and growth, but not compensatory plasticity, of neuromuscular synapses.

Authors:  Megan C Wright; Srilatha Potluri; Xueyong Wang; Eva Dentcheva; Dinesh Gautam; Alan Tessler; Jürgen Wess; Mark M Rich; Young-Jin Son
Journal:  J Neurosci       Date:  2009-11-25       Impact factor: 6.167

8.  The GAR-3 muscarinic receptor cooperates with calcium signals to regulate muscle contraction in the Caenorhabditis elegans pharynx.

Authors:  Katherine A Steger; Leon Avery
Journal:  Genetics       Date:  2004-06       Impact factor: 4.562

Review 9.  Positive allosteric modulation of M1 and M4 muscarinic receptors as potential therapeutic treatments for schizophrenia.

Authors:  Samantha E Yohn; P Jeffrey Conn
Journal:  Neuropharmacology       Date:  2017-09-09       Impact factor: 5.250

10.  Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M4 Muscarinic Receptor.

Authors:  Mark S Moehle; Tristano Pancani; Nellie Byun; Samantha E Yohn; George H Wilson; Johnathan W Dickerson; Daniel H Remke; Zixiu Xiang; Colleen M Niswender; Jürgen Wess; Carrie K Jones; Craig W Lindsley; Jerri M Rook; P Jeffrey Conn
Journal:  Neuron       Date:  2017-12-20       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.